Encompass Health Corporation (EHC) Guidance & Earnings Results
On 2026-08-05 Encompass Health Corporation raised guidance: "FY revenue guidance raised to $6.41-6.49B from $6.375-6.47B; adjusted EBITDA to $1.365-1.395B from $1.35-1.38B; adjusted EPS to $6.02-6.25 from…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
EHCEncompass Health CorporationFollow EHC — free
—
Price chart with a free account
- Market cap
- 12.2B
- P/E TTM
- 20.2
- Dividend yield
- 0.6%
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 5 Aug 26 | Raised | FY revenue guidance raised to $6.41-6.49B from $6.375-6.47B; adjusted EBITDA to $1.365-1.395B from $1.35-1.38B; adjusted EPS to $6.02-6.25 from $5.89-6.11 · full year |
| 5 Feb 26 | Raised | 2026 revenue guidance $6,365-$6,465M, adjusted EBITDA $1,340-$1,380M · full year |
| 29 Oct 25 | Raised | Revenue guidance raised to $5,905-$5,955M (from $5,880-$5,980); EBITDA to $1,235-$1,255M (from $1,220-$1,250); EPS to $5.22-$5.37 (from $5.12-$5.34) · full year |
| 4 Aug 25 | Raised | FY2025 revenue raised to $5,880-5,980M from $5,850-5,925M; Adjusted EBITDA raised to $1,220-1,250M from $1,185-1,220M; Adjusted EPS raised to $5.12-5.34 from $4.85-5.10 · full year |
Encompass Health Corporation — questions
- What guidance did Encompass Health Corporation give?
- On 2026-08-05: "FY revenue guidance raised to $6.41-6.49B from $6.375-6.47B; adjusted EBITDA to $1.365-1.395B from $1.35-1.38B; adjusted EPS to $6.02-6.25 from $5.89-6.11"
- When does Encompass Health Corporation report earnings?
- Encompass Health Corporation's next earnings report is expected on 2026-10-28.
Every figure on this page comes from Encompass Health Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.